BRIEF-AbbVie says expects FDA to grant priority review to hepatitis c drugs

Fri Jan 31, 2014 10:02am EST

Jan 31 (Reuters) - AbbVie Inc : * Says expects FDA to grant priority review to hepatitis c drugs * Says expects FDA to act on hepatitis c drug applications within 8 months or

sooner after receiving them

FILED UNDER: